The most common adverse effects include nausea, vomiting, diarrhea, constipation, decreased appetite, and abdominal discomfort
Start your intake Half-Life, Accumulation, and Steady-State Concentration Semaglutide's 7-day half-life means that after one week, 50% of the previous dose remains in circulation
In clinical trials , people taking Mounjaro lost more weight, with those on the highest dose (15 mg) shedding up to 21 pounds, compared to a maximum of 11 pounds with Ozempic
retatrutide FDA approval
Eligibility criteria We included RCTs with a duration of intervention of at least 12 weeks that compared tirzepatide at a maintenance dose of 5, 10 or 15 mg once-weekly, administered subcutaneously, with placebo or any other glucose-lowering medication